![]() |
Name |
Melleolide K
|
Molecular Formula | C23H27ClO6 | |
IUPAC Name* |
[(2R,2aS,4aS,7aS,7bR)-3-formyl-2a-hydroxy-6,6,7b-trimethyl-1,2,4a,5,7,7a-hexahydrocyclobuta[e]inden-2-yl] 3-chloro-4,6-dihydroxy-2-methylbenzoate
|
|
SMILES |
CC1=C(C(=CC(=C1Cl)O)O)C(=O)O[C@@H]2C[C@]3([C@@]2(C(=C[C@H]4[C@@H]3CC(C4)(C)C)C=O)O)C
|
|
InChI |
InChI=1S/C23H27ClO6/c1-11-18(15(26)6-16(27)19(11)24)20(28)30-17-9-22(4)14-8-21(2,3)7-12(14)5-13(10-25)23(17,22)29/h5-6,10,12,14,17,26-27,29H,7-9H2,1-4H3/t12-,14+,17-,22-,23+/m1/s1
|
|
InChIKey |
UHFQTECWVLYLBG-PPUVGZBRSA-N
|
|
Synonyms |
Melleolide K; [(2R,2As,4aS,7aS,7bR)-3-formyl-2a-hydroxy-6,6,7b-trimethyl-1,2,4a,5,7,7a-hexahydrocyclobuta[e]inden-2-yl] 3-chloro-4,6-dihydroxy-2-methylbenzoate
|
|
CAS | NA | |
PubChem CID | 9910824 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 434.9 | ALogp: | 5.2 |
HBD: | 3 | HBA: | 6 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 104.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 30 | QED Weighted: | 0.475 |
Caco-2 Permeability: | -4.762 | MDCK Permeability: | 0.00002270 |
Pgp-inhibitor: | 0.004 | Pgp-substrate: | 0.01 |
Human Intestinal Absorption (HIA): | 0.014 | 20% Bioavailability (F20%): | 0.053 |
30% Bioavailability (F30%): | 0.003 |
Blood-Brain-Barrier Penetration (BBB): | 0.443 | Plasma Protein Binding (PPB): | 98.59% |
Volume Distribution (VD): | 1.118 | Fu: | 2.37% |
CYP1A2-inhibitor: | 0.675 | CYP1A2-substrate: | 0.472 |
CYP2C19-inhibitor: | 0.818 | CYP2C19-substrate: | 0.314 |
CYP2C9-inhibitor: | 0.876 | CYP2C9-substrate: | 0.804 |
CYP2D6-inhibitor: | 0.784 | CYP2D6-substrate: | 0.184 |
CYP3A4-inhibitor: | 0.684 | CYP3A4-substrate: | 0.42 |
Clearance (CL): | 5.808 | Half-life (T1/2): | 0.405 |
hERG Blockers: | 0.155 | Human Hepatotoxicity (H-HT): | 0.347 |
Drug-inuced Liver Injury (DILI): | 0.182 | AMES Toxicity: | 0.203 |
Rat Oral Acute Toxicity: | 0.068 | Maximum Recommended Daily Dose: | 0.959 |
Skin Sensitization: | 0.77 | Carcinogencity: | 0.8 |
Eye Corrosion: | 0.06 | Eye Irritation: | 0.776 |
Respiratory Toxicity: | 0.911 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002788 | ![]() |
0.705 | D04GJN | ![]() |
0.254 | ||
ENC005899 | ![]() |
0.681 | D0C8HR | ![]() |
0.252 | ||
ENC000887 | ![]() |
0.515 | D06AEO | ![]() |
0.248 | ||
ENC003224 | ![]() |
0.505 | D0E9KA | ![]() |
0.246 | ||
ENC002145 | ![]() |
0.391 | D0F1EX | ![]() |
0.240 | ||
ENC005503 | ![]() |
0.345 | D07DVK | ![]() |
0.240 | ||
ENC002726 | ![]() |
0.322 | D0R6RC | ![]() |
0.239 | ||
ENC003451 | ![]() |
0.309 | D0P0HT | ![]() |
0.236 | ||
ENC003450 | ![]() |
0.309 | D08PIQ | ![]() |
0.234 | ||
ENC003839 | ![]() |
0.304 | D03IKT | ![]() |
0.230 |